Alignment Healthcare Q2 revenue jumps on membership growth
Alignment Healthcare Q2 revenue jumps on membership growth
Overview
US Medicare Advantage insurer's Q2 revenue grew 31.6% yr/yr, beating analyst expectations
Q2 adjusted EBITDA rose 48% yr/yr and beat analyst expectations
Company raised midpoint of full-year guidance for membership, revenue, adjusted gross profit, and adjusted EBITDA
Outlook
Alignment Healthcare raises midpoint of full-year guidance for membership, revenue, adj gross profit, adj EBITDA
Company expects Q3 revenue between $1.3 bln and $1.32 bln
Company sees 2026 full-year revenue between $5.195 bln and $5.225 bln
Result Drivers
MEMBERSHIP GROWTH - Co said 31.5% year-over-year increase in Medicare Advantage membership supported revenue growth
INVESTMENTS IN CLINICAL MODEL AND TECHNOLOGY - Co attributed results to ongoing investments in clinical model, AI-enabled capabilities and operational infrastructure
IMPROVED MEDICAL BENEFITS RATIO - Co reported medical benefits ratio improved by about 40 basis points year-over-year
Company press release: ID:nGNX515WSr
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Beat | $1.34 bln | $1.31 bln (11 Analysts) |
Q2 Net Income |
| $36.56 mln |
|
Q2 Adjusted EBITDA | Beat | $68.15 mln | $57.68 mln (13 Analysts) |
Q2 EBIT |
| $42.10 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the managed healthcare peer group is "buy"
Wall Street's median 12-month price target for Alignment Healthcare Inc is $25.00, about 36.7% above its July 29 closing price of $18.29
The stock recently traded at 57 times the next 12-month earnings vs. a P/E of 93 three months ago
Reuters Recommended Reads
July 29 - Humana leaves annual adjusted profit outlook unchanged, shares drop
July 28 - Trump administration to end Medicare premium subsidy program
July 30 - Cigna raises annual profit forecast on strength in specialty drug unit
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Alignment Healthcare
See all newsBrief: Alignment Healthcare Earns 4 Stars Or Higher For Six Of Seven Eligible Medicare Advantage Contracts In CMS 2027 Star Ratings
U.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
Alignment Healthcare Inc reports results for the quarter ended June 30 - Earnings Summary
Alignment Healthcare Q2 revenue jumps on membership growth
Brief: Alignment Healthcare Q2 Revenue USD 1,335.6 Million Vs. IBES Estimate USD 1,310 Million